Govt. ramps up Amphotericin B manufacturing to fight Mucormycosis
The Department of Pharma has allocated this drug amongst the states/UTs based on expected supply that will be available from May 10 to May 31, 2021
The Department of Pharma has allocated this drug amongst the states/UTs based on expected supply that will be available from May 10 to May 31, 2021
Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases
State governments and UTs have been asked to monitor proper distribution within the state/UT covering government and private hospitals
The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production
Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India
The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India
Market penetration of Sputnik V will depend on competitive pricing, government orders and the ability to meet soaring demand through timely supply
The country has constantly worked with the spirit of public-private partnership
Report outlines the wide array of investment opportunities in various segments of India’s healthcare sector
Lonza Specialty Ingredients has become LifeClean’s first strategic industrial partner.
Subscribe To Our Newsletter & Stay Updated